Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor of Peripheral Nerve”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01058330
What this trial is testing

Effects of Physical Training on Bone and Muscle Quality, Muscle Strength, and Motor Coordination in Children With NF1

Who this might be right for
Neurofibromatosis Type 1
Shriners Hospitals for Children 36
Testing effectiveness (Phase 2)Looking for participantsNCT06553365
What this trial is testing

Phase II Study of FCN-159 in NF2 Nerve Sheath Tumors

Who this might be right for
Nerve Sheath Tumor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Looking for participantsNCT04750928
What this trial is testing

Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas

Who this might be right for
Neurofibromatosis 1
National Cancer Institute (NCI) 55
Large-scale testing (Phase 3)Study completedNCT00026312
What this trial is testing

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma

Who this might be right for
Localized Resectable NeuroblastomaLocalized Unresectable NeuroblastomaRecurrent Neuroblastoma+3 more
National Cancer Institute (NCI) 1,449
Not applicableUnknownNCT05781919
What this trial is testing

Use of Virtual Reality for Surgical Planning in Neuroblastoma

Who this might be right for
Neuroblastoma
Hospital Sant Joan de Deu 130
Testing effectiveness (Phase 2)Looking for participantsNCT05849662
What this trial is testing

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

Who this might be right for
Leukemia, Juvenile MyelomonocyticJMMLJCML+2 more
Therapeutic Advances in Childhood Leukemia Consortium 58
Early research (Phase 1)Study completedNCT02107963
What this trial is testing

A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors

Who this might be right for
SarcomaOsteosarcomaNeuroblastoma+1 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)UnknownNCT02771743
What this trial is testing

Response-based Treatment of High-risk Neuroblastoma

Who this might be right for
Newly Diagnosed High Risk Neuroblastoma
Samsung Medical Center 54
Early research (Phase 1)Study completedNCT00107458
What this trial is testing

Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors

Who this might be right for
Brain and Central Nervous System TumorsUnspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 26
Not applicableLooking for participantsNCT06502015
What this trial is testing

Biomarkers in Autoimmune Disease of Nervous System

Who this might be right for
Autoimmune Diseases of the Nervous SystemNeuromyelitis Optica Spectrum DisorderMultiple Sclerosis+8 more
Tongji Hospital 50,000
Early research (Phase 1)Ended earlyNCT05429502
What this trial is testing

Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors

Who this might be right for
Neuroblastoma
Novartis Pharmaceuticals 12
Testing effectiveness (Phase 2)Study completedNCT02332902
What this trial is testing

Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T

Who this might be right for
Neurofibromatosis 1
The University of Texas Health Science Center, Houston 24
Testing effectiveness (Phase 2)Ended earlyNCT00202930
What this trial is testing

Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma

Who this might be right for
NeuroblastomaOpsoclonus-myoclonus
Jean M. Tersak, M.D. 4
Testing effectiveness (Phase 2)UnknownNCT02743429
What this trial is testing

Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refractory or Relapsed Neuroblastoma

Who this might be right for
Neuroblastoma
University Medicine Greifswald 40
Early research (Phase 1)Study completedNCT00005647
What this trial is testing

SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck

Who this might be right for
Head and Neck Cancer
Case Comprehensive Cancer Center 12
Testing effectiveness (Phase 2)Looking for participantsNCT06541847
What this trial is testing

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis Type 1
Healx Limited 25
Testing effectiveness (Phase 2)Study completedNCT00089258
What this trial is testing

Biological Therapy in Treating Patients With Neuroblastoma That Has Not Responded to Previous Treatment

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 74
Not applicableLooking for participantsNCT07479446
What this trial is testing

Oliceridine Versus Sufentanil for Postoperative Nausea in Cerebellopontine Angle Surgery

Who this might be right for
PONVCerebellopontine Angle TumorMicrovascular Decompression Surgery+1 more
Xuanwu Hospital, Beijing 174
Early research (Phase 1)Study completedNCT00005576
What this trial is testing

Monoclonal Antibody Therapy With Sargramostim and Interleukin-2 in Treating Children With Neuroblastoma

Who this might be right for
Disseminated NeuroblastomaRecurrent NeuroblastomaRegional Neuroblastoma
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Study completedNCT00003846
What this trial is testing

Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Primitive Neuroectodermal Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastoma
Children's Oncology Group 25
Next Page